Cargando…
The Complex Tail of Circulating Sphingolipids in Atherosclerosis and Cardiovascular Disease
Sphingolipids (SLs) are critical players in a number of cellular processes and have recently been implicated in a large number of human diseases, including atherosclerosis and cardiovascular disease (CVD). SLs are generated intracellularly in a stepwise manner, starting with the generation of the sp...
Autores principales: | Zelnik, Iris D., Kim, Jiyoon L., Futerman, Anthony H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Lipidology and Atherosclerosis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473959/ https://www.ncbi.nlm.nih.gov/pubmed/34621698 http://dx.doi.org/10.12997/jla.2021.10.3.268 |
Ejemplares similares
-
Sphingolipids in Atherosclerosis: Chimeras in Structure and Function
por: Peters, Lisa, et al.
Publicado: (2022) -
Sphingolipids in cardiovascular diseases and metabolic disorders
por: Borodzicz, Sonia, et al.
Publicado: (2015) -
Dependence of ABCB1 transporter expression and function on distinct sphingolipids generated by ceramide synthases-2 and -6 in chemoresistant renal cancer
por: Lee, Wing-Kee, et al.
Publicado: (2021) -
Potential therapeutic targets for atherosclerosis in sphingolipid metabolism
por: Yu, Zemou, et al.
Publicado: (2019) -
Circulating Sphingolipids and Glucose Homeostasis: An Update
por: Ali-Berrada, Sarah, et al.
Publicado: (2023)